John M. Aletta

John M. Aletta is a Co-Founder and the Director of Research at CH3 BioSystems. In 1997, his laboratory was the first to demonstrate a requirement for specific protein methylation in the cellular development of neuronal model systems.

As a faculty member in the Department of Pharmacology and Toxicology at the University at Buffalo School of Medicine & Biomedical Sciences, John spent 17 years teaching and contributing peer-reviewed research in the fields of post-translational protein modification and methylation biology.

Since October 2007, he now serves full time as the Principal Scientist at CH3 BioSystems. Through his longstanding professional contacts, CH3 BioSystems has developed a global network of manufacturing and distribution partners. He received his doctoral degree while working in the Center for Neurobiology and Behavior at the Columbia University College of Physicians and Surgeons in New York City in 1984. In addition, he earned two Masters level degrees in Pharmacology at Columbia University (M.A. 1980 and M.Phil. 1981) prior to completing the Ph.D.

Following postdoctoral training in Cellular and Molecular Biology in the laboratory of Lloyd A. Greene at New York University, Dr. Aletta returned to the Columbia College of Physicians and Surgeons as a faculty member in the Department of Pathology. In 1990 he came to Buffalo, New York to join the faculty at the University at Buffalo School of Medicine.